PTGS2 and neoplasm: Following the COX-1/2 inhibition analyses of ortho-[18F]F-58 (COX-2 IC50 = 39.0 nM, COX-1 = 24.5 mM), the radioligand was tested for COX-2 uptake in CAA cells and tumor models.